Prognostic values of biomarkers in COPD

A. Agusti (Barcelona, Spain)

Source: Annual Congress 2013 –Natural history of COPD: novel aspects
Session: Natural history of COPD: novel aspects
Session type: Symposium
Number: 5004
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Agusti (Barcelona, Spain). Prognostic values of biomarkers in COPD. Annual Congress 2013 –Natural history of COPD: novel aspects

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic assessment in COPD without lung function: the B-AE-D indices
Source: Eur Respir J 2016; 47:1635-1644
Year: 2016



Prognostic features of disability in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 57s
Year: 2004

Prognostic evaluation of COPD patients with pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005

Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Prognostic nutritional index (PNI): A predictive factor for elderly patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020




Prognostic parameters in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Prognostic predictors for survival in patients with COPD using cardiopulmonary testing
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002

Prognostic significance of surrogate measures for FVC in an elderly population
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008


Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014



Prognostic predictors of course sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003

Prognostic and predictive factors for lung cancer
Source: Breathe 2012; 9: 112-122
Year: 2012

Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017



Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013



Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014

The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis
Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020
Year: 2021



Clinical prognostic tools and their use in COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020


The prognostic value of extended lung function characterization in COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020